Eli Lilly to acquire cancer drug maker Kelonia in deal worth up to $7B
Eli Lilly will acquire biotech company Kelonia Therapeutics in a deal worth up to $7 billion, the company said Monday.…
Tag: Lilly
Portal CEO on Lilly Deal for Cancer Biotech CrossBridge
Portal Innovations CEO John Flavin provides a look into the 2026 biotech M&A pipeline and breaks down Eli Lilly’s purported…
Eli Lilly market share drops, Novo Nordisk holds firm as generic weight-loss drugs flood India
The Eli Lilly and Novo Nordisk logos. Mike Blake | Tom Little | Reuters The market share of India’s most…
Eli Lilly opposes Trump MFN drug pricing law, CEO Ricks says
Dave Ricks, CEO of Eli Lilly, speaks in the Oval Office during an event about weight loss drugs at the…
Eli Lilly wins US approval for weight-loss drug in pill form
Stay informed with free updates Simply sign up to the Pharmaceuticals sector myFT Digest — delivered directly to your inbox.…
Eli Lilly GLP-1 pill Foundayo approved for obesity
The U.S. Food and Drug Administration approved Eli Lilly‘s GLP-1 pill, the company said, a major milestone for the Indianapolis-based…
Eli Lilly to acquire Centessa and sleep disorder drugs
Lilly Chair and CEO Dave Ricks speaks during a press conference for Eli Lilly and Company in Houston, Texas, U.S.,…
Jefferies Remains a Buy on Eli Lilly and Company (LLY)
Eli Lilly and Company (NYSE:LLY) is one of the Good Stocks to Buy Now. On March 20, Jefferies reiterated a…
Pharma Giant Eli Lilly Is Paying $2.75 Billion for AI-Designed Drugs
Eli Lilly is betting big that generative AI can do more than just write code and create images. It can…
Eli Lilly Links to ESPN Pat Summitt Reunion, Seeking Medical Stories
Eli Lilly & Co. hopes its sponsorship of an event tied to the heroic coach Pat Summitt will do just…